Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Spriet-Pourra

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
L'Encephale|January 1, 1983
[What phase IV should be like for an anxiolytic agent]A Spriet, C Spriet-Pourra, P Simon
Therapie|May 1, 1988
[Cardiogenic shock and major intraventricular block in treatment with cibenzoline]M F Aymard Dufour, C Spriet Pourra
JAMA|November 23, 1979
Postmarketing follow-upH Jick, A M Walker, C Spriet-Pourra
Therapie|January 1, 1982
[Methods of adverse drug reactions monitoring. II. Frequencies estimations (author's transl)]C Spriet-Pourra, A Spriet, C Soubrie, et al.
Therapie|November 1, 1981
[Methods of adverse drug reaction monitoring. I,Collection of data and type of studies (author's transl)]C Spriet-Pourra, A Spriet, C Soubrie, et al.
Therapie|September 1, 1985
[Critical study of methods of postmarketing drug surveillance]J P Gut, M Auriche, C Spriet-Pourra, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
L'Encephale|January 1, 1983
[What phase IV should be like for an anxiolytic agent]A Spriet, C Spriet-Pourra, P Simon
Therapie|May 1, 1988
[Cardiogenic shock and major intraventricular block in treatment with cibenzoline]M F Aymard Dufour, C Spriet Pourra
JAMA|November 23, 1979
Postmarketing follow-upH Jick, A M Walker, C Spriet-Pourra
Therapie|January 1, 1982
[Methods of adverse drug reactions monitoring. II. Frequencies estimations (author's transl)]C Spriet-Pourra, A Spriet, C Soubrie, et al.
Therapie|November 1, 1981
[Methods of adverse drug reaction monitoring. I,Collection of data and type of studies (author's transl)]C Spriet-Pourra, A Spriet, C Soubrie, et al.
Therapie|September 1, 1985
[Critical study of methods of postmarketing drug surveillance]J P Gut, M Auriche, C Spriet-Pourra, et al.
Pageof 1